Exploring Antibodies, Small Molecules & Nanoparticles for Increased Movement of Oligonucleotide Therapeutics Across the Blood Brain Barrier
Time: 1:00 pm
day: Day One
- Uncovering considerations for each therapeutic modality from a therapeutic perspective
- Exploring molecule design considerations for moving across the blood brain barrier more readily
- Are there recommendations to consider for antibodies, small molecules, nanoparticles and peptides?